换一批Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial
第一作者：
Luke, Jason J.
作者：
Luke, Jason J. [1]
;
Rutkowski, Piotr [2]
;
Queirolo, Paola [3]
;
Del Vecchio, Michele [4]
;
Mackiewicz, Jacek [5]
;
Chiarion-Sileni, Vanna [6]
;
Merino, Luis de la Cruz [7]
;
Khattak, Muhammad A. [8]
;
Schadendorf, Dirk [9]
;
Long, Georgina, V [10]
;
Ascierto, Paolo A. [11]
;
Mandala, Mario [12]
;
De Galitiis, Federica [13]
;
Haydon, Andrew [14]
;
Dummer, Reinhard [15]
;
Grob, Jean-Jacques [16]
;
Robert, Caroline [17]
;
Carlino, Matteo S. [18]
;
Mohr, Peter [19]
;
Poklepovic, Andrew [20]
;
Sondak, Vernon K. [21]
;
Scolyer, Richard A. [22]
;
Kirkwood, John M. ;
Chen, Ke ;
Diede, Scott J. ;
Ahsan, Sama ;
Ibrahim, Nageatte ;
Eggermont, Alexander M. M. ;
KEYNOTE-716 Investigators
作者单位：
UPMC Hillman Canc Ctr
[1]
Maria Sklodowska Curie Natl Res Inst Oncol
[2]
Ist Europe Oncol IRCCS
[3]
Inst Gustave Roussy
[4]
Melanoma Inst Australia,Univ Sydney
[5]
Elbe Kliniken Buxtehude
[6]
Fdn IRCCS Ist Nazl Tumori
[7]
Poznan Univ Med Sci
[8]
Ist Oncol Veneto,IOV IRCCS
[9]
Clin Oncol Dept,Hosp Univ Virgen Macarena
[10]
Fiona Stanley Hosp
[11]
Univ Hosp Essen
[12]
Ist Nazl Tumori IRCCS Fdn Pascale
[13]
Univ Perugia
[14]
Dermopath Inst Immaculate,IDI IRCCS
[15]
Alfred Hosp,Monash Univ
[16]
Univ Hosp Zurich,Univ Zurich
[17]
AP HM Hosp,Aix Marseille Univ
[18]
Massey Canc Ctr
[19]
H Lee Moffitt Canc Ctr & Res Inst
[20]
Merck & Co Inc
[21]
Univ Med Ctr Utrecht
[22]
发布时间
2022-08-26
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
